Elanix Biotechnologies AG (FRA:ELN) EV-to-FCF : -2.10 (As of May. 30, 2024)

Elanix Biotechnologies AG EV-to-FCF Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
EV-to-FCF		Get a 7-Day Free Trial					-25.64	-28.73	-32.13	-6.18	-4.33

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Elanix Biotechnologies AG's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's EV-to-FCF falls into.

Elanix Biotechnologies AG EV-to-FCF Calculation

Elanix Biotechnologies AG's EV-to-FCF for today is calculated as:

Elanix Biotechnologies AG's current Enterprise Value is €4.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elanix Biotechnologies AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2018 was €-2.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG  (FRA:ELN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Elanix Biotechnologies AG's PE Ratio for today is calculated as:

Elanix Biotechnologies AG's share price for today is €0.053.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elanix Biotechnologies AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2018 was €-12.490.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Elanix Biotechnologies AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description